Ru/Beta Zeolite Catalysts for Levulinic Acid Hydrogenation: The Importance of Catalyst Synthesis Methodology

被引:1
作者
Petcuta, Oana Adriana [1 ]
Guzo, Nicolae Cristian [1 ]
Bordeiasu, Mihai [1 ]
Nicolaev, Adela [2 ]
Parvulescu, Vasile I. [1 ]
Coman, Simona M. [1 ]
机构
[1] Univ Bucharest, Fac Chem, Dept Inorgan Chem Organ Chem Biochem & Catalysis, Bdul Regina Elisabeta 4-12, Bucharest 030016, Romania
[2] Natl Inst Mat Phys, Atomistilor 405b, Magurele Ilfov 077125, Romania
关键词
beta zeolite; ruthenium; deposition-precipitation; levulinic acid; catalytic hydrogenation; gamma-valerolactone; DEPOSITION-PRECIPITATION METHOD; GAMMA-VALEROLACTONE; SELECTIVE HYDROGENATION; PHASE HYDROGENATION; CONVERSION; RUTHENIUM; WATER; RU; STABILITY; SUPPORT;
D O I
10.3390/catal15010080
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Ruthenium-based catalysts were prepared through a deposition-precipitation approach, taking beta zeolites with Si/Al ratios of 12.5, 18.5, and 150, respectively, as supports, and 1-3 wt% loadings of metal. Their activation was performed in the presence of either H2 or NaBH4. The dispersion of the Ru species and the acid-base properties were influenced by both the preparation method and the activation protocol. The catalysts reduced under H2 flow presented well-dispersed Ru(0) and RuOx nanoparticles, while the reduction with NaBH4 led to larger RuOx crystallites and highly dispersed Ru(0). These characteristics exerted an important role in the hydrogenation of levulinic acid (LA) to gamma-valerolactone (GVL). The H2 dissociation occurred via a heterolytic mechanism involving Lewis acid-base pairs associated with RuOx and the framework oxygen (Si-O-Al) located near the zeolite pore edge. The Ru(0) nanoparticles activated the -C=O bond of the LA substrate, while the presence of the carrier zeolite Br & oslash;nsted acid sites promoted the ring-closure esterification of the 4-hydroxyvaleric acid (4-HVA) intermediate to GVL. An optimal combination of these features was achieved for the catalyst with 3 wt% Ru and a Si/Al ratio of 150, which selectively converted LA (XLA = 96.5%) to GVL (SGVL = 97.8%) at 130 degrees C and 10 bars of H2.
引用
收藏
页数:20
相关论文
共 61 条
[1]  
Abusuek D.A., 2021, Chem. Eng. Trans, V88, P277, DOI [10.3303/CET2188046, DOI 10.3303/CET2188046]
[2]   ZSM-5 as a support for Ru-containing catalysts of levulinic acid hydrogenation: Influence of the reaction conditions and the zeolite acidity [J].
Abusuek, Dialia A. ;
Tkachenko, Olga P. ;
V. Bykov, Alexey ;
Sidorov, Alexander I. ;
Matveeva, Valentina G. ;
Sulman, Mikhail G. ;
Nikoshvili, Linda Zh. .
CATALYSIS TODAY, 2023, 423
[3]   Heterolytic Dissociation of H2 in Heterogeneous Catalysis [J].
Aireddy, Divakar R. ;
Ding, Kunlun .
ACS CATALYSIS, 2022, 12 (08) :4707-4723
[4]   Exploring the ruthenium catalysed synthesis of γ-valerolactone in alcohols and utilisation of mild solvent-free reaction conditions [J].
Al-Shaal, Mohammad G. ;
Wright, William R. H. ;
Palkovits, Regina .
GREEN CHEMISTRY, 2012, 14 (05) :1260-1263
[5]   Gamma-valerolactone, a sustainable platform molecule derived from lignocellulosic biomass [J].
Alonso, David Martin ;
Wettstein, Stephanie G. ;
Dumesic, James A. .
GREEN CHEMISTRY, 2013, 15 (03) :584-595
[6]   In-situ XPS analysis of oxidized and reduced plasma deposited ruthenium-based thin catalytic films [J].
Balcerzak, Jacek ;
Redzynia, Wiktor ;
Tyczkowski, Jacek .
APPLIED SURFACE SCIENCE, 2017, 426 :852-855
[7]  
BHAT RN, 1990, J CHEM TECHNOL BIOT, V48, P453
[8]   UiO-66 derived Ru/ZrO2@C as a highly stable catalyst for hydrogenation of levulinic acid to γ-valerolactone [J].
Cao, Wenxiu ;
Luo, Wenhao ;
Ge, Hongguang ;
Su, Yang ;
Wang, Aiqin ;
Zhang, Tao .
GREEN CHEMISTRY, 2017, 19 (09) :2201-2211
[9]   CONVERSION OF METHANOL AND OTHER O-COMPOUNDS TO HYDROCARBONS OVER ZEOLITE CATALYSTS [J].
CHANG, CD ;
SILVESTRI, AJ .
JOURNAL OF CATALYSIS, 1977, 47 (02) :249-259
[10]   Heterogeneous Diastereoselective Catalysis - A Powerful Strategy Toward C(15) Stereoselectivity from PGF2α Analogues Structure [J].
Coman, Simona M. ;
Parvulescu, Vasile I. .
CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (38) :5558-5572